Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-lactate dehydrogenase A chain (LDHA) is a key enzyme in anaerobic glycolysis, catalyzing the reversible conversion of pyruvate to L-lactate. It is essential for energy production in low-oxygen conditions and is highly expressed in muscle tissue and many tumors. LDHA supports tumor development, invasion, and metastasis by enabling metabolic adaptation under hypoxia. Mutations can cause metabolic disorders, and elevated levels are associated with tissue damage and disease states.
Inhibition of LDHA enzymatic activity, disrupting tumor metabolism by blocking lactate production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-lactate dehydrogenase A chain (LDHA).